Advarra has selected TransPerfect Life Sciences as its strategic supplier of language services, including document translation, digital content localization, and interpretation services.
SIRO Clinpharm is in “a new area of growth” following the procurement of ArisGlobal’s LifeSphere Clinical platform, which has enabled the company to expand its business prospects, says CRO.
The number of new clinical trials in the regenerative market space continues to grow, says Cryport, which will provide global logistics support for TiGenix’s upcoming Phase Ib/IIa study.
Vical has dismissed 40 employees and abandoned a Phase III vaccine candidate in a reshuffle it says allows for greater resources on HSV-2 and antifungal trials.
An update to guidance on patient payments in clinical trials has been released by the US FDA, urging institutional review boards and investigators be wary of undue influence impacting subject consent.
CTI Clinical Trial and Consulting Services (CTI) has opened a new office in Singapore – a location that will enable the CRO to attract and retain talent as it continues expansion in Asia.
Weill Cornell Medicine has joined TriNetX’s global health research network, enabling it to collaborate with researchers and attract clinical trial opportunities.
Apple has updated its Health app to give users access to their medical records – a new feature that could fundamentally change the way research is conducted, says Medidata.
SQN Clinical has launched SQN Health, a mobile electronic Patient Reported Outcomes (ePRO) and Clinical Outcome Assessment (eCOA) application, which provides real-time and ongoing patient and data oversight.
The US Food and Drug Administration (FDA) is launching a new pilot program this month aimed at increasing clinical trial transparency – though many opportunities remain to improve the scope, clarity, and usability of data, says TrialScope CSO.
Revisions to the Federal Policy for the Protection of Human Subjects has been delayed six months, possibly more, as regulators cite the rule’s complexity, lack of guidance, and other challenges.
Celerion has integrated its proprietary electronic data acquisition system, ClinQuick, with OmniComm’s electronic data capture (EDC) solution, TrialMaster, to create a fully automated clinical trial data management platform.
LabCorp’s Covance has launched a new dedicated offering for biotech, medical device, and diagnostic companies following its purchase of Chiltern in 2017.
This past year, the clinical trials landscape continued to shift and adapt to promising trends—including mobile technology, real-world data, and patient engagement—that can help us build a stronger clinical trials system.
The pharmaceutical industry made significant advancements towards global regulatory harmonization in 2017 – despite a highly-charged political environment on both sides of the Atlantic.
Outsourcing models examined, market shifts scrutinized, and trial tribulations analyzed – take a look back at some of the top reports published in 2017.
The Good Pharma Scorecard aims to quantify what makes a “good” pharmaceutical company – as 91% of Americans think companies put money before people, says Bioethics International founder.
The National Institutes of Health (NIH) has created a new clinical trials consortium with a model focused on streamlining research and diverse recruitment.
By Doug Peddicord, PhD, executive director of the Association of Clinical Research Organizations (ACRO)
As the great Yogi Berra once said, “It’s tough to make predictions, especially about the future.” But it is safe to say that after a year of considerable consolidation and change, the CRO industry anticipates continuing and potentially rapid evolution...
Arrowhead Pharmaceuticals says it is looking to move six candidates into the clinic within the next year thanks to its newly unveiled RNAi delivery platform.
Advertising, social media and individualised patient recruitment strategies can improve participation numbers according to clinical site executives, who say they favour a personalised approach.
Parexel has launched its first offering as part of its alliance with Microsoft, through which the companies are looking to redefine the life sciences industry, says CRO.
By Sudip S. Parikh, PhD, senior vice president & managing director, DIA Americas
The healthcare product development ecosystem is undergoing massive changes. Significant transformations are underway in how drugs and medical devices are researched, developed, manufactured, and approved.
Compass Pathways has selected Worldwide Clinical Trials to conduct studies of its investigational psychoactive therapy, designed for patients with treatment-resistant depression.
The US Food and Drug Administration (FDA) has released a new draft guidance as part of its stated commitment to assist sponsors and expedite drug development for rare pediatric diseases.
Crucial Data Solutions, Inc. and its strategic partner Zircon Technologies have teamed up to release a “first-of-its-kind” software solution developed to accelerate the clinical trials process.
By Dennis Salotti, vice president of operations, The Avoca Group
Making the shift in the pharmaceutical industry from a risk-averse approach to overseeing clinical trials to a risk-based approach is – quite frankly – earthshaking.
Transitioning to a single strategic contract research organization (CRO) reduced Bayer’s administrative burden, but the restructuring was met with some resistance, said the firm.
Icon plc has launched a new digital solution aimed at increasing the efficiency and quality of patient eligibility assessments as the industry continues to struggle with clinical trial recruitment.
Quanticate has launched an upgraded statistical monitoring service following the ICH’s good clinical practice (GCP) E6(R2) addendum designed to streamline clinical trials.
The industry is expected to use an increasing amount of real world evidence, including social media data, which will be used to support new drug applications, according to a recent Tufts report.
Acorda Therapeutics has halted enrolment for a trial of its Parkinson’s disease candidate tozadenant after the emergence of serious adverse events, including five deaths.
Evotec is collaborating with academic institutions to develop a device to test drug candidates in the kidney, which it says could improve and accelerate clinical trials.
Pfizer has sold its share of a joint venture with Zhejiang Hisun Pharmaceuticals but will continue supporting the local production of generic drugs in China.
The industry has reached an inflection point with 200 new health-related apps added daily – the use of which could lead to potential annual savings of $46bn, says IQVIA.
Devana Solutions has released a new platform to help align top performing sites with sponsors and contract research organizations (CROs) as consolidation will make it important to stand out amongst the competition, says CEO.
